Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in adult cohort: a real‐life Italian tertiary centre experience-Reference-Cited by-同舟云学术

Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in adult cohort: a real‐life Italian tertiary centre experience

Published:2020-05-22 Issue:8 Volume:34 Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Ribero S.¹^ORCID,Giura M.T.¹^ORCID,Viola R.²,Ramondetta A.¹,Siliquini N.¹^ORCID,Cardone P.¹,Tonella L.¹,Quaglino P.¹,Dapavo P.¹,Panzone M.¹,Ortoncelli M.¹,Fierro M.T.¹

Affiliation:

1. Medical Sciences Department Dermatologic Clinic University of Turin Turin Italy

2. Faculty of Medicine University of Turin Turin Italy

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.16219

Reference10 articles.

1. Atopic dermatitis

2. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

3. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

4. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t

5. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Burden of Disease in Real-Life Setting of Patients With Atopic Dermatitis: Italian Data From the MEASURE-AD Study;Dermatology Practical & Conceptual;2024-01-31

2. Efficacy and safety of abrocitinib in patients with moderate‐to‐severe atopic dermatitis and comorbid allergies;Allergy;2023-11-21

3. Effect of abrocitinib and dupilumab on eosinophil levels in patients with moderate‐to‐severe atopic dermatitis;JEADV Clinical Practice;2023-06-23

4. Long‐term psychological outcome of patients with moderate‐to‐severe atopic dermatitis continuously treated with Dupilumab: Data up to 3 years;Experimental Dermatology;2023-03-10

5. Lichen ruber planus arising during dupilumab treatment for atopic dermatitis;Italian Journal of Dermatology and Venereology;2022-10